Replies to post #4982 on Jaguar Health Inc (JAGX)

[ShadowDiviner72]

Another note: The VP told me they actually wanted to present the data at SABCS, which is logical since they received the results in september.

But he told me, they were too late for the submission date of SABCS, which is months in front. I think it is July, since JAGX allready submitted their HALT-D data that month according to 2021 PR's. So, they were too late, and had to submit for AACR.

I have the feeling the same thing happened with JAGX. Data was later than expected, SABCS passed by, and once the abstract was ready, even the submission date for AACR allready passed... The submission date for ASCO , for LBA, was beginning of this month, so logically they had time to submit. Once submitted, they follow the embargo policy, hence the delay to Q2

[TJG]

Shadow Napa is Lisa... they were a floundering company and she came along and took them over and they became a subsiderary of Jaguar for the sole purpose of having boots on the ground in Europe... they also for EU reasons made them the lead on the Crofelemer projects... as for Anderson, they were chosen to be the Investigator of the study... by definition they are responsible to ensure the study is run according to the FDA requirements... they Do Not have any sway after the study is completed... they can not tell the company what they have to do with the results once they are available and there is No Mandator requirement they attend a conference of any type before they can announce the results. The second link show that they are NOT bound to do a conference or anything else before publishing the results to the public

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051859/#:~:text=Investigators%20are%20responsible%20for%20supervising,the%20investigator%20maintains%20ultimate%20responsibility.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213793/